SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-059158
Filing Date
2011-10-31
Accepted
2011-10-31 15:17:45
Documents
14
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-26671_110q.htm 10-Q 1086642
2 EX-10.1 a11-26671_1ex10d1.htm EX-10.1 386343
3 EX-10.2 a11-26671_1ex10d2.htm EX-10.2 754956
4 EX-31.1 a11-26671_1ex31d1.htm EX-31.1 10050
5 EX-31.2 a11-26671_1ex31d2.htm EX-31.2 9900
6 EX-32.1 a11-26671_1ex32d1.htm EX-32.1 5343
7 EX-32.2 a11-26671_1ex32d2.htm EX-32.2 5335
14 GRAPHIC g266711ka05i001.jpg GRAPHIC 3083
  Complete submission text file 0001104659-11-059158.txt   4623400

Data Files

Seq Description Document Type Size
8 EX-101.INS pcrx-20110930.xml EX-101.INS 402333
9 EX-101.SCH pcrx-20110930.xsd EX-101.SCH 14545
10 EX-101.CAL pcrx-20110930_cal.xml EX-101.CAL 49754
11 EX-101.LAB pcrx-20110930_lab.xml EX-101.LAB 262518
12 EX-101.PRE pcrx-20110930_pre.xml EX-101.PRE 124518
13 EX-101.DEF pcrx-20110930_def.xml EX-101.DEF 88770
Mailing Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 111168096
SIC: 2834 Pharmaceutical Preparations